Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.94
-
NAV
₹37.59
-
Fund Started
12 Nov 2018
-
Fund Size
₹2891.76 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 1 month.
-
1 Year
1.35%
-
3 Year
20.44%
-
5 Year
13.07%
-
Equity
97.66%
-
Cash
2.34%
-
Top 10 Holdings
Ipca Laboratories Ltd. | 9.39% |
Sun Pharmaceutical Industries Ltd. | 9.33% |
Cipla Ltd. | 7.68% |
Globus Medical Inc | 7.58% |
Illumina Inc. (USA) | 6.47% |
Laurus Labs Ltd. | 6.29% |
Sai Life Sciences Ltd. | 6.02% |
Gland Pharma Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.00% |
Alembic Pharmaceuticals Ltd. | 3.28% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
12 Nov 2018
-
